Delivery Order SPE2DB22D2214-SPE2DB25FS5VU
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Bepotastine 1.5% eye drops. The $1,270.95 firm fixed-price contract has a completion date of June 25, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,189.06 firm-fixed-price delivery order is for the supply of MIEBO 100% Eye Drop 3ML, a medical product, with a completion date of December 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency awarded a $1,765.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ML) on July 21, 2025, with completion expected by July 22, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a $8,694.78 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of MIEBO 100% Eye Drop in 3ML units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for ultimate completion on July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,957.57 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $14,193.62 to AmerisourceBergen Drug Corp for MIEBO 100% Eye Drop (3ml) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price delivery order carries no set-aside designation and reflects a competitive award to the prime contractor. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and operates as a...
- The Defense Logistics Agency awarded a $24,495 delivery order to AmerisourceBergen Drug Corp for MIEBO 100% eye drop product (3ML units) on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed price, competitively awarded contract carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical supplier to...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,010.02, is for the supply of a 0.1% eye drop medication (VEVYE 2ML). The contract has an ultimate completion date of July 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $44,937.60 firm fixed-price delivery order is for the provision of MIEBO 100% Eye Drop 3ML, a medical product. The contract has an ultimate completion date of December 12, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a $9,971.22 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of loteprednol etabonate 0.5% eye drops. This delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS5VUDelivery Order
The Defense Logistics Agency awarded a $10,596.78 firm fixed price delivery order to AmerisourceBergen Drug Corp for Bepotastine 1.5% eye drop medication (10ml units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems. As the prime contractor under the SPE2DX IDC—a comprehensive global pharmaceutical support vehicle—the company supplies an extensive portfolio of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The underlying IDC enables AmerisourceBergen to serve customers including the Defense Health Agency and U.S. Coast Guard, with the DLA planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts for multiple regions in the coming years.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 7/21/25 |